XGenomes
XGenomes is building the sequencing technology of the future.
Cambridge, United States · Founded 2017 · $3.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2017
- Website
- xgenomes.com
- Total Funding
- $3.0M
- Last Round
- $3.0M SeedAug 2019
- Rounds
- 1
About
At XGenomes, we are building a technology comprising novel biochemistry, hardware and algorithms for sequencing DNA. Our product will be streamlined: there is zero library preparation; we sequence directly on unadulterated single molecules of DNA; DNA extraction will be integrated with sequencing; there is no bioinformatics bottleneck. The sequence we produce will be of unprecedented accuracy due to several layers of in-built redundancy including the sequencing both strands of the double-helix concurrently. The sequence we produce will be complete, encompassing: structural as well as single nucleotide variants; long-range haplotype phase; the repetitive "dark matter" of the genome. The cost of goods (consumables) of sequencing will be <$10, which will allow us to price our product at a level that will help grow the market while still achieving >90% margin. We will start by offering access as a service to high value customers, which be followed by a razor and blade model of selling instruments and consumables.
Summary
XGenomes is a Genomics company based in Cambridge, United States, founded in 2017. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Aug 2019. Investors include Y Combinator Continuity Fund, Amino Capital and Cantos.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2019
Investors
Similar Companies

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...


